From: Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer
Characteristic | 3DCRT | IMRT | p-value |
---|---|---|---|
Number of patients (n) | 80 | 27 | |
Age (median, range) | 65, 35–85 | 66, 42–84 | 0.57 |
Gender (male/female) | 45/35 | 10/17 | 0.65 |
PS (0–1/2) | 74/6 | 27/0 | 0.33 |
Tumor location(head, uncus/body, tail) | 41/39 | 16/10 | 0.51 |
Tumor size (median, range [mm]) | 29, 19–40 | 30, 10–70 | 0.038 |
Induction chemotherapy (yes/no) | 36/44 | 27/0 | < 0.01 |
Concurrent chemotherapy (Gemcitabine/S-1) | 73/7 | 26/1 | 0.68 |
Radiation dose (median, range [Gy]) | 54, 48.6–55.8 | 48, 39–51 | |
Radiation fractionation (median, range) | 30, 27–31 | 15, 15–15 |